Symbols / CYCC
CYCC Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-11-12 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Insider Sale: 10% owner at $CYCC Sells 6,750 Shares | CYCC Stock News - Quiver Quantitative Mon, 04 Aug 2025 07
- What’s the beta of CYCC stock - Profit Target & Safe Capital Allocation Plans - mfd.ru hu, 12 Feb 2026 07
- Cyclacel Announces Major Share Restructuring: 23.7M Shares Consolidating to 1.58M - Stock Titan Wed, 02 Jul 2025 07
- Cyclacel stock falls after paring 270% gain amid volatility concerns - Investing.com Wed, 16 Jul 2025 07
- BGMS Stock Price and Chart — NASDAQ:BGMS - TradingView Fri, 12 Sep 2025 15
- Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split - Yahoo Finance hu, 03 Jul 2025 07
- Behavioral Patterns of CYCC and Institutional Flows - Stock Traders Daily Sun, 18 Jan 2026 16
- How CYCC stock responds to policy changes - Earnings Growth Summary & Safe Capital Allocation Plans - mfd.ru Fri, 13 Feb 2026 19
- Cyclacel Pharmaceuticals Addresses Recent Stock Price Volatility Amid Ongoing Business Developments - Quiver Quantitative Wed, 16 Jul 2025 07
- Cyclacel Dodges Delisting Risk: Stock Stabilizes Above $1, Secures Crucial Nasdaq Compliance - Stock Titan ue, 03 Jun 2025 07
- Cyclacel Pharmaceuticals Stock Soars: Investing or Waiting? - timothysykes.com ue, 15 Jul 2025 07
- Bio Green Med Solution, Inc. Completes Acquisition of Fitters Sdn. Bhd. to Diversify Business Portfolio - Quiver Quantitative Fri, 12 Sep 2025 07
- Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance Mon, 02 Sep 2024 07
- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future - Yahoo Finance hu, 25 Apr 2024 07
- Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss - Yahoo Finance ue, 12 Nov 2024 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CYCC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|